Ginkgo Bioworks Holdings (DNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 20,156 | 19,474 | 53,954 | 38,837 | 39,134 |
| Cost of Goods | 1,719 | 3,098 | 24,700 | 12,802 | 5,380 |
| Gross Profit | 18,437 | 16,376 | 29,254 | 26,035 | 33,754 |
| Operating Expenses | 77,704 | 87,848 | 116,080 | 116,854 | 92,297 |
| Operating Income | -58,548 | -71,374 | -86,126 | -90,017 | -58,163 |
| Other Income | 1,355 | -4,765 | -10,021 | 9,263 | 4,686 |
| Pre-tax Income | -57,193 | -76,139 | -96,147 | -80,754 | -53,477 |
| Income Tax | 128 | -80 | -643 | 1 | -283 |
| Net Income Continuous | -57,321 | -76,059 | -95,504 | -80,755 | -53,194 |
| Net Income Discontinuous | 10,611 | -6,528 | N/A | N/A | -7,106 |
| Net Income | $-46,710 | $-82,587 | $-80,751 | $-80,755 | $-60,300 |
| EPS Basic Total Ops | -0.75 | -1.39 | -1.41 | -1.45 | -1.10 |
| EPS Basic Continuous Ops | -0.92 | -1.28 | -1.68 | -1.45 | -0.97 |
| EPS Basic Discontinuous Ops | 0.17 | -0.11 | N/A | N/A | -0.13 |
| EPS Diluted Total Ops | -0.75 | -1.39 | -1.41 | -1.45 | -1.10 |
| EPS Diluted Continuous Ops | -0.92 | -1.28 | -1.68 | -1.45 | -0.97 |
| EPS Diluted Discontinuous Ops | 0.17 | -0.11 | N/A | N/A | -0.13 |
| EPS Diluted Before Non-Recurring Items | N/A | -1.28 | -1.42 | -1.45 | -1.10 |
| EBITDA(a) | $-46,233 | $-58,575 | $-75,853 | $-74,761 | $-42,914 |